TB: Genetic drug resistance tests as good in gauging treatment outcome, death risk as traditional culture-based tests

Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.